Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)

CAPS Rating: 3 out of 5

The Company is a clinical-stage drug development company that discovers and develops novel, small molecule drugs for the treatment of inflammatory diseases, cancer and viral diseases.

Recs

0
Player Avatar Fiskhus (72.87) Submitted: 5/17/2011 12:34:05 AM : Outperform Start Price: $8.06 RIGL Score: -6.38

MB9A

Featured Broker Partners


Advertisement